Sanofi (SNY) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free SNY Stock Alerts $49.13 -0.23 (-0.47%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJennison Associates LLC Makes New $7.93 Million Investment in Sanofi (NASDAQ:SNY)marketbeat.com - April 27 at 6:08 AMSanofi profit slips on generic competition and currency effectsmsn.com - April 26 at 2:35 AMSanofi (NASDAQ:SNY) Shares Gap Up to $46.61marketbeat.com - April 25 at 4:49 PMTyler Technologies Shares Reach 52-Week High Following Strong 1Q Earningsmarketwatch.com - April 25 at 2:59 PMSanofi (SNY) Q1 2024 Earnings Call Transcriptfool.com - April 25 at 2:59 PMSanofi 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - April 25 at 12:17 PMAbbVie reports positive results from Rinvoq versus Dupixent studymsn.com - April 25 at 11:32 AMDrugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earningsbenzinga.com - April 25 at 10:24 AMSNY Stock Earnings: Sanofi Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 9:15 AMSanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buyca.investing.com - April 25 at 7:00 AMSanofi Sales, Profit Beat Forecastswsj.com - April 25 at 3:25 AMSanofi Q1 profit slips on generic competition, forex effectsreuters.com - April 25 at 1:32 AMPress Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceglobenewswire.com - April 25 at 1:30 AMSanofi Asks Banks to Pitch for $20 Billion OTC Spinofffinance.yahoo.com - April 24 at 5:21 AMPress Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopeniaglobenewswire.com - April 23 at 1:00 AMSkyhawk’s latest biopharma collaboration is worth up to $1.8Bbizjournals.com - April 22 at 10:11 PMSanofi reportedly settles 4K Zantac cases for $100Mseekingalpha.com - April 22 at 12:53 PMFoundry Partners LLC Sells 33,690 Shares of Sanofi (NASDAQ:SNY)marketbeat.com - April 21 at 10:35 PMQ2 2024 Earnings Estimate for Sanofi Issued By Leerink Partnrs (NASDAQ:SNY)americanbankingnews.com - April 20 at 2:44 AMParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and Moremsn.com - April 19 at 10:26 AMSanofi to Post Q2 2024 Earnings of $0.91 Per Share, Leerink Partnrs Forecasts (NASDAQ:SNY)marketbeat.com - April 19 at 8:31 AMFederated Hermes Inc. Has $85.40 Million Stake in Sanofi (NASDAQ:SNY)marketbeat.com - April 19 at 8:27 AMSanofi to overhaul US operations of vaccines, cut jobsreuters.com - April 18 at 4:29 PMBrokers Issue Forecasts for Sanofi's Q1 2024 Earnings (NASDAQ:SNY)americanbankingnews.com - April 18 at 5:46 AMSanofi (SNY) Set to Announce Quarterly Earnings on Thursdayamericanbankingnews.com - April 18 at 1:08 AMNovartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Yearsbenzinga.com - April 17 at 12:56 PMCOTA Announces Strategic Collaboration with Sanofi to Leverage Real-World Data and AI to Accelerate Cancer Trialsbusinesswire.com - April 17 at 9:00 AMCookson Peirce & Co. Inc. Sells 484,123 Shares of Sanofi (NASDAQ:SNY)marketbeat.com - April 17 at 8:41 AMSanofi - Aventis Groupe: Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosisfinanznachrichten.de - April 17 at 3:05 AMSanofi (NASDAQ:SNY) Shares Sold by Oak Family Advisors LLCmarketbeat.com - April 15 at 3:32 PMNovo Nordisk Arms Wegovy to Be a Triple Threat (SNY)marketbeat.com - April 15 at 7:30 AMMeitav Investment House Ltd. Decreases Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - April 12 at 12:28 PMRegeneron hits three-month low after DOJ complaint; RBC defendsmsn.com - April 11 at 7:23 PMSanofi to shutter operations at Peninsula drug maker it bought less than 3 years agobizjournals.com - April 11 at 5:38 PMNurix gains after extending Sanofi research pactmsn.com - April 9 at 2:31 PMSanofi (NASDAQ:SNY) Sees Strong Trading Volumemarketbeat.com - April 9 at 12:54 PMMeet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.barrons.com - April 9 at 11:42 AMSanofi - AGM 30.04.2024 - Availability of Preparatory documentsglobenewswire.com - April 8 at 12:00 PMSanofi Layoffs 2024: What to Know About the Latest SNY Job Cutsinvestorplace.com - April 8 at 10:08 AMAugustine Asset Management Inc. Raises Stock Holdings in Sanofi (NASDAQ:SNY)marketbeat.com - April 6 at 8:15 AMSanofi shares target cut amid FDA Dupixent reviewinvesting.com - April 5 at 4:42 AMSanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groupsbusinesswire.com - April 5 at 4:15 AMChina Universal Asset Management Co. Ltd. Grows Stake in Sanofi (NASDAQ:SNY)marketbeat.com - April 4 at 6:54 PMDiabetes Drug Lixisenatide May Slow Down Parkinson's: Studyfinanznachrichten.de - April 4 at 4:38 PMSanofi to Resolve 4,000 Zantac Cancer Lawsuits in US Courtsmsn.com - April 4 at 1:42 PMIn Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Clusterbenzinga.com - April 4 at 10:09 AMDiabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trialcnbc.com - April 4 at 9:56 AMDiabetes medication appears to slow progress of Parkinson’s disease in French-backed trialmsn.com - April 4 at 7:56 AMSanofi to Settle About 4,000 Suits Over Zantac Cancer Claimsmsn.com - April 3 at 7:28 PMSanofi to settle 4,000 Zantac cancer lawsuits in US state courtsreuters.com - April 3 at 5:33 PM Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. SNY Media Mentions By Week SNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.450.32▲Average Medical News Sentiment SNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼218▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VRTX News REGN News BMY News PFE News GSK News ZTS News ABT News TAK News NVS News BIIB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
